{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:47:06Z","timestamp":1794019626136,"version":"4.8.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010203","name":"WRAIR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010203","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jviromet.2025.115296","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:10:44Z","timestamp":1761959444000},"page":"115296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A split GFP approach to assay SARS-CoV-2 spike-dependent cell fusion"],"prefix":"10.1016","volume":"340","author":[{"given":"M. Jane","family":"Morwitzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying Yi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Friberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5696-0268","authenticated-orcid":false,"given":"Jeffrey R.","family":"Currier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2025.115296_bib1","doi-asserted-by":"crossref","first-page":"488","DOI":"10.15585\/mmwr.mm7218a3","article-title":"Provisional mortality data \u2014 United States, 2022","volume":"72","author":"Ahmad","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.jviromet.2025.115296_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105546","article-title":"Spike-mediated viral membrane fusion is inhibited by a specific anti-IFITM2 monoclonal antibody","volume":"211","author":"Basile","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jviromet.2025.115296_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105316","article-title":"Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron","volume":"25","author":"Benlarbi","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.jviromet.2025.115296_bib4","unstructured":"Bilodeau, A., 2024. The Pros and Cons of Adherent Versus Suspension Cell Culture. BioPharm International, BioPharm International, January 2024 37, 18\u201322."},{"key":"10.1016\/j.jviromet.2025.115296_bib5","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1007\/s11033-022-08193-4","article-title":"Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective","volume":"50","author":"Borkotoky","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jviromet.2025.115296_bib6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41586-021-03491-6","article-title":"Drugs that inhibit TMEM16 proteins block SARS-CoV-2 Spike-induced syncytia","volume":"594","author":"Braga","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2025.115296_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103104","article-title":"Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology","volume":"61","author":"Bussani","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jviromet.2025.115296_bib8","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1038\/srep02854","article-title":"A new protein-protein interaction sensor based on tripartite split-GFP association","volume":"3","author":"Cabantous","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jviromet.2025.115296_bib9","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/s41591-024-02987-8","article-title":"Three-year outcomes of post-acute sequelae of COVID-19","volume":"30","author":"Cai","year":"2024","journal-title":"Nat. Med"},{"key":"10.1016\/j.jviromet.2025.115296_bib10","first-page":"162","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat. Rev. Microbiol"},{"key":"10.1016\/j.jviromet.2025.115296_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1007527","article-title":"Fusion assays for screening of fusion inhibitors targeting SARS-CoV-2 entry and syncytia formation","volume":"13","author":"Chan","year":"2022","journal-title":"Front. Pharm."},{"key":"10.1016\/j.jviromet.2025.115296_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12985-023-02062-7","article-title":"Ultrastructural study confirms the formation of single and heterotypic syncytial cells in bronchoalveolar fluids of COVID-19 patients","volume":"20","author":"Chaudhary","year":"2023","journal-title":"Virol. J."},{"key":"10.1016\/j.jviromet.2025.115296_bib13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV \u2014 a target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat. Rev. Microbiol"},{"key":"10.1016\/j.jviromet.2025.115296_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41591-019-0746-2","article-title":"Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor","volume":"26","author":"Dussupt","year":"2020","journal-title":"Nat. Med"},{"key":"10.1016\/j.jviromet.2025.115296_bib15","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/s41590-021-01068-z","article-title":"Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations","volume":"22","author":"Dussupt","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jviromet.2025.115296_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41564-024-01878-5","article-title":"Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic","volume":"10","author":"Furnon","year":"2025","journal-title":"Nat. Microbiol"},{"key":"10.1016\/j.jviromet.2025.115296_bib17","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.medj.2023.08.006","article-title":"Ancestral, Delta, and Omicron (BA.1) SARS-CoV-2 strains are dependent on serine proteases for entry throughout the human respiratory tract","volume":"4","author":"Gartner","year":"2023","journal-title":"Med"},{"key":"10.1016\/j.jviromet.2025.115296_bib18","doi-asserted-by":"crossref","first-page":"12910","DOI":"10.1074\/jbc.REV120.013930","article-title":"The molecular virology of coronaviruses","volume":"295","author":"Hartenian","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jviromet.2025.115296_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103255","article-title":"Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity","volume":"65","author":"Hoffmann","year":"2021","journal-title":"eBioMedicine"},{"key":"10.1016\/j.jviromet.2025.115296_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jviromet.2025.115296_bib21","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1080\/22221751.2022.2125348","article-title":"Structure-based neutralizing mechanisms for SARS-CoV-2 antibodies","volume":"11","author":"Huang","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jviromet.2025.115296_bib22","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1038\/s41467-022-33911-8","article-title":"Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways","volume":"13","author":"Iwata-Yoshikawa","year":"2022","journal-title":"Nat. Commun. Nat. Commun."},{"key":"10.1016\/j.jviromet.2025.115296_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jviromet.2025.115296_bib24","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021107821","article-title":"TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells","volume":"40","author":"Koch","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.jviromet.2025.115296_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.yexcr.2015.06.015","article-title":"A new cell-based assay to evaluate myogenesis in mouse myoblast C2C12 cells","volume":"336","author":"Kodaka","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jviromet.2025.115296_bib26","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.1038\/s41467-023-42726-0","article-title":"The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis","volume":"14","author":"Kostka","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jviromet.2025.115296_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2025.115296_bib28","doi-asserted-by":"crossref","first-page":"9644","DOI":"10.3390\/ijms21249644","article-title":"Virus-Mediated Cell-Cell Fusion","volume":"21","author":"Leroy","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jviromet.2025.115296_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.07.012","article-title":"The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jviromet.2025.115296_bib30","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s10529-006-9147-y","article-title":"Characterization of matrix metalloproteinase expressed by human embryonic kidney cells","volume":"28","author":"Liu","year":"2006","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.jviromet.2025.115296_bib31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1021\/ja046699g","article-title":"Detecting protein\u2212protein interactions with a green fluorescent protein fragment reassembly trap:\u2009scope and mechanism","volume":"127","author":"Magliery","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jviromet.2025.115296_bib32","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","article-title":"Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity","volume":"603","author":"Meng","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2025.115296_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/v15020271","article-title":"TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection","volume":"15","author":"Metzdorf","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.jviromet.2025.115296_bib34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/bs.mie.2022.07.015","article-title":"Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples","volume":"675","author":"Meyrath","year":"2022","journal-title":"Methods Enzym."},{"key":"10.1016\/j.jviromet.2025.115296_bib35","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.chom.2021.06.006","article-title":"SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity","volume":"29","author":"Motozono","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jviromet.2025.115296_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00851-23","article-title":"SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models","volume":"97","author":"Mykytyn","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2025.115296_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105869","article-title":"Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antivirals","volume":"225","author":"P\u00e9rez-Vargas","year":"2024","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jviromet.2025.115296_bib38","doi-asserted-by":"crossref","first-page":"e00171-23","DOI":"10.1128\/mbio.00171-23","article-title":"Adaptive variations in SARS-CoV-2 spike proteins: effects on distinct virus-cell entry stages","volume":"14","author":"Qing","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.jviromet.2025.115296_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167280","article-title":"The mechanism and consequences of SARS-CoV-2 spike-mediated fusion and syncytia formation","volume":"434","author":"Rajah","year":"2022","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jviromet.2025.115296_bib40","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3390\/v15071500","article-title":"SARS-CoV-2 Spike Protein Is Capable of Inducing Cell\u2013Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies","volume":"15","author":"Reuter","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.jviromet.2025.115296_bib41","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12033-021-00299-7","article-title":"Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro)","volume":"63","author":"Rothan","year":"2021","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.jviromet.2025.115296_bib42","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41586-021-04266-9","article-title":"Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation","volume":"602","author":"Saito","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2025.115296_bib43","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3390\/v15051129","article-title":"SARS-CoV-2 omicron specific mutations affecting infectivity, fusogenicity, and partial TMPRSS2-independency","volume":"15","author":"Strobelt","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.jviromet.2025.115296_bib44","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41586-022-04462-1","article-title":"Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant","volume":"603","author":"Suzuki","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2025.115296_bib45","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41576-021-00408-x","article-title":"The biological and clinical significance of emerging SARS-CoV-2 variants","volume":"22","author":"Tao","year":"2021","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/j.jviromet.2025.115296_bib46","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1002\/jmv.28053","article-title":"Rapid quantitative monitoring of SARS-CoV-2 spike protein-mediated syncytia formation using split NanoLuc","volume":"94","author":"Wang","year":"2022","journal-title":"J. Med. Virol."},{"issue":"11","key":"10.1016\/j.jviromet.2025.115296_bib47","doi-asserted-by":"crossref","first-page":"103393","DOI":"10.1016\/j.isci.2021.103393","article-title":"Functional differences among the spike glycoproteins of multiple emerging severe actue respiratory syndrome coronavirus 2 variants of concern","volume":"24","author":"Wang","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.jviromet.2025.115296_bib48","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2210237","article-title":"Impaired potency of neutralizing antibodies against cell\u2013cell fusion mediated by SARS-CoV-2","volume":"12","author":"Wang","year":"2023","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.jviromet.2025.115296_bib49","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.vaccine.2023.02.008","article-title":"Protective effect of COVID-19 vaccination against long COVID syndrome: a systematic review and meta-analysis","volume":"41","author":"Watanabe","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2025.115296_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110812","article-title":"LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants","volume":"39","author":"Westendorf","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.jviromet.2025.115296_bib51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nmeth1204-255","article-title":"Detecting protein-protein interactions with GFP-fragment reassembly","volume":"1","author":"Wilson","year":"2004","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jviromet.2025.115296_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102619","article-title":"Mechanism and evolution of human ACE2 binding by SARS-CoV-2 spike","volume":"81","author":"Wrobel","year":"2023","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jviromet.2025.115296_bib53","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cell.2022.11.030","article-title":"SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming","volume":"186","author":"Wu","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jviromet.2025.115296_bib54","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"Xia","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.jviromet.2025.115296_bib55","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41423-020-0374-2","article-title":"Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein","volume":"17","author":"Xia","year":"2020","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.jviromet.2025.115296_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00519-22","article-title":"Metalloproteinase-dependent and TMPRSS2-independent cell surface entry pathway of SARS-CoV-2 requires the furin cleavage site and the S2 domain of spike protein","volume":"13","author":"Yamamoto","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.jviromet.2025.115296_bib57","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3390\/v12060629","article-title":"The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner","volume":"12","author":"Yamamoto","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.jviromet.2025.115296_bib58","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1128\/AAC.01043-16","article-title":"Identification of nafamostat as a potent inhibitor of middle east respiratory syndrome coronavirus S Protein-mediated membrane fusion using the split-protein-based cell-cell fusion assay","volume":"60","author":"Yamamoto","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jviromet.2025.115296_bib59","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111400119","article-title":"SARS-CoV-2 spreads through cell-to-cell transmission","volume":"119","author":"Zeng","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jviromet.2025.115296_bib60","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1038\/s41418-021-00782-3","article-title":"SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination","volume":"28","author":"Zhang","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jviromet.2025.115296_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009683","article-title":"Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2","volume":"17","author":"Zhao","year":"2021","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.jviromet.2025.115296_bib62","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-024-01940-y","article-title":"Enhancing RBD exposure and S1 shedding by an extremely conserved SARS-CoV-2 NTD epitope","volume":"9","author":"Zhu","year":"2024","journal-title":"Sig Transduct Target Ther"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093425001892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093425001892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T05:37:07Z","timestamp":1764999427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093425001892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":62,"alternative-id":["S0166093425001892"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2025.115296","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A split GFP approach to assay SARS-CoV-2 spike-dependent cell fusion","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2025.115296","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115296"}}